间充质干细胞
诱导多能干细胞
细胞生物学
干细胞
胚状体
再生医学
胚胎干细胞
间充质干细胞的临床应用
生物
干细胞移植修复关节软骨
软骨发生
组织工程
细胞分化
细胞疗法
成体干细胞
遗传学
基因
作者
Yan Zhou,Jinqi Liao,Chongzhou Fang,Cuiping Mo,Guangqian Zhou,Yonglun Luo
出处
期刊:Bio-protocol
[Bio-Protocol]
日期:2018-01-01
卷期号:8 (22)
被引量:7
标识
DOI:10.21769/bioprotoc.3080
摘要
Mesenchymal stem cells (MSCs) are invaluable cell sources for understanding stem cell biology and potential application in tissue engineering and regenerative medicine. The current issues of MSCs that demand to be further addressed are limited donors, tissue sources and limited capacity of ex vivo expansion. Here, we describe a simple and easy protocol for generating functional mesenchymal stem cells from human pluripotent stem cells (hPSCs) via one-step low glucose medium switch strategy in feeder-free culture system. In this protocol, human induced pluripotent stem cells (hiPSCs) and H9 human embryonic stem cells (hESCs) were successfully differentiated into MSCs, named hiPSC-MSCs and hESC-MSCs, respectively. The derived hiPSC-MSCs and hESC-MSCs exhibited common MSC characteristics as MSCs derived from human bone marrow (hBM-MSCs), including expressing MSC surface markers and possessing capability of tri-lineage differentiation in vitro (adipogenesis, osteogenesis and chondrogenesis). As compared with other available protocols, our protocol can be applied to generate a large number of MSCs from hPSCs with high efficiency, low-cost manner, moreover, not involving embryoid body, mouse feeder-cell, flow sorting, and pathway inhibitors (such as SB203580 and SB431542). We believe that this protocol could provide a robust platform to reach the future demand for producing the industrial scale of MSC from hPSCs for autologous cell-based therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI